Systemic fungal infections, including aspergillosis and mucormycosis, significantly increased in patients with hematologic malignancies. Early empiric antifungal therapy is crucial for improving outcomes in these high-risk patients.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science: